Nobody has realised how significant for A2 the Synlait announcement about lactoferrin is. A2 is the only company Synlait puts lactoferrin in the infant formula.
Moreover its only in the land bounded infant formula A2 is putting in Chinese stores- means on land demand must be growing very very fast.
The icing on the cake is Synlait has a license from the FDA in the US to import lactoferrin into the US only one of 2 licenses issued.
Look for massive growth in infant formula mainland sales by A2 and look towards an A2 infant formula product for the US.
Let the short termers play I am very relaxed Annual should be a blast!
-
- There are more pages in this discussion • 15,061 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$7.95 |
Change
-0.320(3.87%) |
Mkt cap ! $5.755B | |||
| Open | High | Low | Value | Volume |
| $8.25 | $8.25 | $7.95 | $11.06M | 1.377M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | $7.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.99 | 13595 | 4 |
View Market Depth
| Last trade - 16.16pm 23/06/2025 (20 minute delay) ? |
| A2M (ASX) Chart |